Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Gastric Cancer

  Free Subscription


1 Ann Surg
2 BMC Cancer
1 BMC Gastroenterol
1 BMC Surg
1 Br J Surg
3 Dig Dis Sci
1 Endoscopy
1 Eur J Surg Oncol
1 J Gastroenterol Hepatol
3 Lancet Oncol
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Surg

  1. SEO N, Han K, Hyung WJ, Chung YE, et al
    Stratification of Postsurgical Computed Tomography Surveillance Based on the Extragastric Recurrence of Early Gastric Cancer.
    Ann Surg. 2020;272:319-325.
    PubMed         Abstract available

    BMC Cancer

  2. YANG C, Shi Y, Xie S, Chen J, et al
    Short-term outcomes of robotic- versus laparoscopic-assisted Total Gastrectomy for advanced gastric Cancer: a propensity score matching study.
    BMC Cancer. 2020;20:669.
    PubMed         Abstract available

  3. MATSUMOTO T, Yamamoto Y, Kuriona Y, Okazaki U, et al
    Efficacy and safety of nivolumab for advanced gastric cancer patients with poor performance statuses.
    BMC Cancer. 2020;20:684.
    PubMed         Abstract available

    BMC Gastroenterol

  4. OHNO A, Miyoshi J, Kato A, Miyamoto N, et al
    Endoscopic severe mucosal atrophy indicates the presence of gastric cancer after Helicobacter pylori eradication -analysis based on the Kyoto classification.
    BMC Gastroenterol. 2020;20:232.
    PubMed         Abstract available

    BMC Surg

  5. TSEKREKOS A, Triantafyllou T, Klevebro F, Hayami M, et al
    Implementation of minimally invasive gastrectomy for gastric cancer in a western tertiary referral center.
    BMC Surg. 2020;20:157.
    PubMed         Abstract available

    Br J Surg

  6. SAUNDERS JH, Yanni F, Dorrington MS, Bowman CR, et al
    Impact of postoperative complications on disease recurrence and long-term survival following oesophagogastric cancer resection.
    Br J Surg. 2020;107:103-112.
    PubMed         Abstract available

    Dig Dis Sci

  7. TOYA Y, Endo M, Oizumi T, Akasaka R, et al
    Risk Factors for Post-gastric Endoscopic Submucosal Dissection Bleeding with a Special Emphasis on Anticoagulant Therapy.
    Dig Dis Sci. 2020;65:557-564.
    PubMed         Abstract available

  8. KIM GH, Ahn JY, Gong CS, Kim M, et al
    Efficacy of Endoscopic Ultrasound-Guided Fine-Needle Biopsy in Gastric Subepithelial Tumors Located in the Cardia.
    Dig Dis Sci. 2020;65:583-590.
    PubMed         Abstract available

  9. WATANABE H, Hayano K, Ohira G, Imanishi S, et al
    Quantification of Structural Heterogeneity Using Fractal Analysis of Contrast-Enhanced CT Image to Predict Survival in Gastric Cancer Patients.
    Dig Dis Sci. 2020 Jul 20. pii: 10.1007/s10620-020-06479.
    PubMed         Abstract available


  10. PAPPAS A, Tan WK, Waldock W, Richardson S, et al
    Single-bite versus double-bite technique for mapping biopsies during endoscopic surveillance for hereditary diffuse gastric cancer: a single-center, randomized trial.
    Endoscopy. 2020 Jul 17. doi: 10.1055/a-1201-3125.
    PubMed         Abstract available

    Eur J Surg Oncol

  11. WANG X, Sun J, Zhang W, Yang X, et al
    Use of radiomics to extract splenic features to predict prognosis of patients with gastric cancer.
    Eur J Surg Oncol. 2020 Jun 27. pii: S0748-7983(20)30545.
    PubMed         Abstract available

    J Gastroenterol Hepatol

  12. UEYAMA H, Kato Y, Akazawa Y, Yatagai N, et al
    Application of artificial intelligence using a convolutional neural network for diagnosis of early gastric cancer based on magnifying endoscopy with narrow-band imaging.
    J Gastroenterol Hepatol. 2020 Jul 17. doi: 10.1111/jgh.15190.
    PubMed         Abstract available

    Lancet Oncol

  13. JANJIGIAN YY, Maron SB, Chatila WK, Millang B, et al
    First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial.
    Lancet Oncol. 2020;21:821-831.
    PubMed         Abstract available

  14. SAMALIN E, Adenis A
    TAS-118 plus oxaliplatin in advanced gastric cancer: is it worth it?
    Lancet Oncol. 2020 Jul 16. pii: S1470-2045(20)30337.

  15. KANG YK, Chin K, Chung HC, Kadowaki S, et al
    S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial.
    Lancet Oncol. 2020 Jul 16. pii: S1470-2045(20)30315.
    PubMed         Abstract available

    PLoS One

  16. CHOI YJ, Ohn JH, Kim N, Kim W, et al
    Family-based exome sequencing combined with linkage analyses identifies rare susceptibility variants of MUC4 for gastric cancer.
    PLoS One. 2020;15:e0236197.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.